{
    "cancelStatus": "0",
    "cancelDate": null,
    "cancelReason": [],
    "licid": "51061087",
    "validDate": "2027-03-18 00:00:00.000",
    "issueDate": "2022-03-18 00:00:00.000",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHY05106108709",
    "prodNameC": "\"霖揚\"多賜特舒注射液20毫克\/毫升",
    "prodNameE": "Docetaxel Injection 20mg\/mL \"GBC\"",
    "indicationsName": [
        "1.乳癌 與doxorubicin和cyclophosphamide併用適用於可手術切除具有淋巴結轉移及無淋巴結轉移的乳癌病人的術後輔助療法。對於可接受手術切除且無淋巴結轉移的乳癌病人，輔助療法僅限用於可接受化學治療的病人，該化療方式則是遵照國際標準對早期乳癌之主要治療方式。-與Doxorubicin併用適用局部晚期或轉移性乳癌且先前未曾接受過化學治療之病人。-單獨使用，適用於治療局部晚期或轉移性且前次化學治療失敗之乳癌病人。-與trastuzmab併用，可用於治療腫瘤HER2過度表現且先前未曾接受過化學治療的轉移性乳癌病人。-與capecitabine併用於治療對化學治療包括anthracycline無效之局部晚期或轉移性乳癌病人。2.非小細胞肺癌 -與cisplatin併用適用於局部晚期或轉移性非小細胞肺癌，且先前未曾接受過化學治療之病人。Docetaxel與carboplatin併用為另一含鉑之治療選擇。-適用於對含鉑之化學療法失敗的局部晚期或轉移性之非小細胞肺癌。3.前列腺癌 -與prednisone或prednisolone併用適用於荷爾蒙治療無效之轉移性前列腺癌。4.胃腺癌 -與cisplatin及5-fluorouracil併用適用於晚期胃腺癌病人，包括胃食道接合處之腺癌，且先前未曾接受過化學治療之病人。5.頭頸癌 -與cisplatin及5-fluorouracil併用適用於頭頸部局部進行性鱗狀細胞癌病人放射治療前的引導性化療。"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "1毫升玻璃注射瓶裝",
            "packageUnit": ""
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "B",
    "ingredientsDesc": [
        "DOCETAXEL"
    ],
    "restraintItemsCode": [
        "01",
        "24"
    ],
    "applicantName": "霖揚生技製藥股份有限公司",
    "applicantAddr": "苗栗縣竹南鎮頂埔里科研路50-3號4樓、50-5號4樓、50-8號3樓、50-8號4樓、50-8號5樓、50-9號5樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "霖揚生技製藥股份有限公司",
            "factoryAddr": "苗栗縣竹南鎮頂埔里科研路50-3號4樓、50-5號4樓、50-8號3樓、50-8號4樓、50-8號5樓、50-9號5樓",
            "factoryCompanyAddr": "",
            "countryCode": "TW",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "6135041295",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000200",
            "ingredientsDesc": "DOCETAXEL",
            "concentDesc": "Docetaxel Trihydrate.....21.34mg (eq. to Docetaxel.....20mg)",
            "concent": "21.340",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01CD02"
        }
    ]
}